Skip Navigation

JNCI Journal of the National Cancer Institute 2006 98(1):3-4; doi:10.1093/jnci/djj008
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Prosnitz, L. R.
Right arrow Articles by Marks, L. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prosnitz, L. R.
Right arrow Articles by Marks, L. B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press.

EDITORIAL

Postmastectomy Radiotherapy: Quality Counts!

Leonard R. Prosnitz, Lawrence B. Marks

Affiliation of authors: Department of Radiation Oncology, Duke University Medical Center, Durham, NC

Correspondence to: Leonard R. Prosnitz, MD, Department of Radiation Oncology, Duke University Medical Center, Box 3085 Medical Center, Durham, NC 27710 (e-mail: prosnitz@radonc.duke.edu).

The first 10% of the full text of this article appears below.

It seems like such a simple idea. It is surprising that no one has ever done it before.

In this issue of the Journal, Gebski et al. (1) from Australia revisit the issue of postmastectomy radiation therapy and its effects on survival with a meta-analysis of 36 trials and a reanalysis of the Early Breast Cancer Trialists' Collaborative Group (EBCTCG) report (2). What is new is that Gebski et al. make an effort to control for the quality of radiation therapy in these trials.

The trials were categorized as "optimal" with regard to radiation therapy dose and treatment volume . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JNCI J Natl Cancer InstHome page
I. Kunkler, N. Russell, P. Canney, K. Venables, and J. Bartlett
Re: Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective.
J Natl Cancer Inst, July 19, 2006; 98(14): 1020 - 1021.
[Full Text] [PDF]